315 related articles for article (PubMed ID: 29544974)
1. Development and validation of ultra-performance liquid chromatography method for the determination of meloxicam and its impurities in active pharmaceutical ingredients.
Louati K; Bargaoui I; Safta F
Ann Pharm Fr; 2018 May; 76(3):187-200. PubMed ID: 29544974
[TBL] [Abstract][Full Text] [Related]
2. A novel stability-indicating UPLC method development and validation for the determination of seven impurities in various diclofenac pharmaceutical dosage forms.
Azougagh M; Elkarbane M; Bakhous K; Issmaili S; Skalli A; Iben Moussad S; Benaji B
Ann Pharm Fr; 2016 Sep; 74(5):358-69. PubMed ID: 27475309
[TBL] [Abstract][Full Text] [Related]
3. UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.
Kumar N; Sangeetha D; Reddy SP
J Chromatogr Sci; 2012 Oct; 50(9):810-9. PubMed ID: 22661461
[TBL] [Abstract][Full Text] [Related]
4. Development of a stability-indicating UPLC method for determining olanzapine and its associated degradation products present in active pharmaceutical ingredients and pharmaceutical dosage forms.
Krishnaiah Ch; Vishnu Murthy M; Kumar R; Mukkanti K
J Pharm Biomed Anal; 2011 Mar; 54(4):667-73. PubMed ID: 21075576
[TBL] [Abstract][Full Text] [Related]
5. A validated stability-indicating UPLC method for the determination of impurities in Maraviroc.
Chilukuri M; Hussainreddy K; Narayanareddy P; Venkataramana M
J Chromatogr Sci; 2014 Aug; 52(7):609-16. PubMed ID: 23825352
[TBL] [Abstract][Full Text] [Related]
6. Stability-indicating UPLC method for determination of Imatinib Mesylate and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms.
Nageswari A; Reddy KV; Mukkanti K
J Pharm Biomed Anal; 2012 Jul; 66():109-15. PubMed ID: 22502910
[TBL] [Abstract][Full Text] [Related]
7. A new RP-HPLC method for analysis of meloxicam in tablets.
Arayne MS; Sultana N; Siddiqui FA
Pak J Pharm Sci; 2005 Jan; 18(1):58-62. PubMed ID: 16431386
[TBL] [Abstract][Full Text] [Related]
8. Method development and validation for the simultaneous determination of meloxicam and pridinol mesylate using RP-HPLC and its application in drug formulations.
Vignaduzzo SE; Castellano PM; Kaufman TS
J Pharm Biomed Anal; 2008 Jan; 46(2):219-25. PubMed ID: 17961953
[TBL] [Abstract][Full Text] [Related]
9. Stability-indicating UPLC method for determining related substances and degradants in dronedarone.
Pydimarry SP; Cholleti VK; Vangala RR
J Chromatogr Sci; 2014 Aug; 52(7):666-75. PubMed ID: 23863770
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
[TBL] [Abstract][Full Text] [Related]
11. Development of a new stability indicating method for the simultaneous separation of voriconazole from its impurities along with sodium benzoate used as a preservative in a powder for oral suspension.
Elleuch A; Louati K; Turki M; Khalfallah K; Safta F
Ann Pharm Fr; 2019 Sep; 77(5):394-417. PubMed ID: 31257019
[TBL] [Abstract][Full Text] [Related]
12. Stability-indicating UPLC method for determination of Valsartan and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms.
Krishnaiah Ch; Reddy AR; Kumar R; Mukkanti K
J Pharm Biomed Anal; 2010 Nov; 53(3):483-9. PubMed ID: 20646890
[TBL] [Abstract][Full Text] [Related]
13. Determination of meloxicam in bulk and pharmaceutical formulations.
Zawilla NH; Abdul-Azim Mohammad M; El kousy NM; El-Moghazy Aly SM
J Pharm Biomed Anal; 2003 Aug; 32(6):1135-44. PubMed ID: 12907256
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a selective, sensitive and stability indicating UPLC-MS/MS method for rapid, simultaneous determination of six process related impurities in darunavir drug substance.
A VBR; Yusop Z; Jaafar J; Aris AB; Majid ZA; Umar K; Talib J
J Pharm Biomed Anal; 2016 Sep; 128():141-148. PubMed ID: 27262107
[TBL] [Abstract][Full Text] [Related]
15. Method development and validation for the analysis of meloxicam in tablets by CZE.
Nemutlu E; Kir S
J Pharm Biomed Anal; 2003 Feb; 31(2):393-400. PubMed ID: 12609679
[TBL] [Abstract][Full Text] [Related]
16. A novel reverse phase stability indicating RP-UPLC method for the quantitative determination of fifteen related substances in Ranolazine drug substance and drug product.
Malati V; Reddy AR; Mukkanti K; Suryanarayana MV
Talanta; 2012 Aug; 97():563-73. PubMed ID: 22841123
[TBL] [Abstract][Full Text] [Related]
17. A novel and rapid validated stability-indicating UPLC method of related substances for dorzolamide hydrochloride and timolol maleate in ophthalmic dosage form.
Sharma N; Rao SS; Reddy AM
J Chromatogr Sci; 2012 Oct; 50(9):745-55. PubMed ID: 22562819
[TBL] [Abstract][Full Text] [Related]
18. A validated stability-indicative UPLC method for nilotinib hydrochloride for the determination of process-related and degradation impurities.
Kondra SB; Madireddy V; Chilukuri M; Papadasu N; Jonnalagadda L
J Chromatogr Sci; 2014 Sep; 52(8):880-5. PubMed ID: 24029617
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous Determination of Impurities of Atazanavir and Ritonavir in Tablet Dosage Form by Using Reversed-Phase Ultra Performance Liquid Chromatographic Method.
Mantripragada MKVVN; Rao SV; Nutulapati VVS; Mantena BPV
J Chromatogr Sci; 2018 Mar; 56(3):270-284. PubMed ID: 29300835
[TBL] [Abstract][Full Text] [Related]
20. Determination of meloxicam in human plasma using a HPLC method with UV detection and its application to a pharmacokinetic study.
Bae JW; Kim MJ; Jang CG; Lee SY
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Nov; 859(1):69-73. PubMed ID: 17921074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
